 | Up a level |
Journal Article
Goetze, T. O., Al-Batran, S-E., Zander, T., Reichart, A., Lindig, U., Kleiss, M., Mueller, L., Bolling, C., Seufferlein, T., Reichardt, P., Kullmann, F., Eschenburg, H., Schmittel, A., Egger, M., Block, A., Pauligk, C. and Schmalenberg, H. (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Goetze, T. O., Schmalenberg, H., Pauligk, C., Zander, T., Reichart, A., Lindig, U., Kleiss, M., Mueller, L., Bolling, C., Seufferlein, T., Reichardt, P., Kullmann, F., Eschenburg, H., Schmittel, A., Egger, M., Block, A. and Al-Batran, S. -E. (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). Oncol. Res. Treat., 40. S. 209 - 210. BASEL: KARGER. ISSN 2296-5262
Sinn, M., Liersch, T., Riess, H., Gellert, K., Stuebs, P., Waldschmidt, D., Lammert, F., Maschmeyer, G., Bechstein, W., Bitzer, M., Denzlinger, C., Hofheinz, R., Lindig, U., Ghadimi, M., Hinke, A., Striefler, J. K., Pelzer, U., Bischoff, S., Bahra, M. and Oettle, H. (2020). CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results. Eur. J. Cancer, 138. S. 172 - 182. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852